JP2023547889A5 - - Google Patents
Info
- Publication number
- JP2023547889A5 JP2023547889A5 JP2023525023A JP2023525023A JP2023547889A5 JP 2023547889 A5 JP2023547889 A5 JP 2023547889A5 JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023525023 A JP2023525023 A JP 2023525023A JP 2023547889 A5 JP2023547889 A5 JP 2023547889A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid residues
- pharmaceutically acceptable
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105678P | 2020-10-26 | 2020-10-26 | |
| US63/105,678 | 2020-10-26 | ||
| US202163193753P | 2021-05-27 | 2021-05-27 | |
| US63/193,753 | 2021-05-27 | ||
| PCT/US2021/047827 WO2022093374A1 (en) | 2020-10-26 | 2021-08-26 | Compounds,compositions and methods of use to treat spinal fusions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547889A JP2023547889A (ja) | 2023-11-14 |
| JP2023547889A5 true JP2023547889A5 (https=) | 2024-09-02 |
Family
ID=81383097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525023A Pending JP2023547889A (ja) | 2020-10-26 | 2021-08-26 | 脊椎融合を治療するための化合物、組成物、および使用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230390363A1 (https=) |
| EP (1) | EP4232075A4 (https=) |
| JP (1) | JP2023547889A (https=) |
| AU (1) | AU2021369193A1 (https=) |
| CA (1) | CA3196688A1 (https=) |
| MX (1) | MX2023004829A (https=) |
| WO (1) | WO2022093374A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019232283A1 (en) | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| US20230399374A1 (en) * | 2020-10-26 | 2023-12-14 | Purdue Research Foundation | Compounds, Compositions and Methods of Use to Treat Bone Fractures |
| WO2024246840A1 (en) * | 2023-06-01 | 2024-12-05 | Radius Health, Inc. | Methods for identification and quantitation of abaloparatide and related peptide impurities |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3045458A1 (en) * | 2016-11-30 | 2018-06-07 | Purdue Research Foundation | Fracture targeted bone regeneration through parathyroid hormone receptor stimulation |
| EP3765488A1 (en) * | 2018-03-12 | 2021-01-20 | Fresenius Kabi iPSUM S.r.l. | Process for the manufacture of pthrp analogue |
| WO2019232283A1 (en) * | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
| US20230399374A1 (en) * | 2020-10-26 | 2023-12-14 | Purdue Research Foundation | Compounds, Compositions and Methods of Use to Treat Bone Fractures |
-
2021
- 2021-08-26 AU AU2021369193A patent/AU2021369193A1/en active Pending
- 2021-08-26 WO PCT/US2021/047827 patent/WO2022093374A1/en not_active Ceased
- 2021-08-26 US US18/033,658 patent/US20230390363A1/en active Pending
- 2021-08-26 JP JP2023525023A patent/JP2023547889A/ja active Pending
- 2021-08-26 CA CA3196688A patent/CA3196688A1/en active Pending
- 2021-08-26 EP EP21887114.3A patent/EP4232075A4/en active Pending
- 2021-08-26 MX MX2023004829A patent/MX2023004829A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023547889A5 (https=) | ||
| JP2024506435A5 (https=) | ||
| JP2023029957A (ja) | 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 | |
| RU2242228C2 (ru) | Композиция для стимулирования роста | |
| JP5544169B2 (ja) | フェニルアルキルカルボン酸誘導体送達剤 | |
| JP2017206561A (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| ES2879947T3 (es) | Derivados de la tirosina y composiciones que los comprenden | |
| JP2022514255A5 (https=) | ||
| RU2019112897A (ru) | Комбинаторная терапия с агонистами cnp контролируемого высвобождения | |
| CN1181760A (zh) | 亲脂性肽类激素衍生物 | |
| JP2010031018A5 (https=) | ||
| RU2007122804A (ru) | Меченные радиоактивным изотопом конъюгаты rgd-содержащих пептидов и способы их получения с помощью click-химии | |
| RU2012121264A (ru) | Терапевтические пептиды | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2024506435A (ja) | 化合物、組成物、および骨折を処置するための使用方法 | |
| JP2022512704A5 (https=) | ||
| EP1878429A1 (en) | Trenadermal absorption preparation | |
| JP2004026678A (ja) | ２型糖尿病治療剤 | |
| JP2023547889A (ja) | 脊椎融合を治療するための化合物、組成物、および使用の方法 | |
| RU99119233A (ru) | Фармацевтические композиции, содержащие ибупрофен и домперидон для лечения мигрени | |
| TW201106964A (en) | A motilin-link peptide compound offering absorptivity via mucous administration | |
| CN1089950A (zh) | 新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用 | |
| RU2003126176A (ru) | Кислотно-аддитивные соли тербинафина и яблочной кислоты | |
| CN104379161A (zh) | 促进血管生长的蛋白质及其用途 | |
| JP5173807B2 (ja) | 活性剤を送達するためのシクロプロピル化合物および組成物 |